These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1311475)

  • 1. Does acute rejection correlate with infection in liver transplantation?
    Höckerstedt K; Butrón T; Salmela K; Ahonen J; Eklund B; Isoniemi H; Holmberg C; Kyllönen L; Lautenschlager I
    Transplant Proc; 1992 Feb; 24(1):296-7. PubMed ID: 1311475
    [No Abstract]   [Full Text] [Related]  

  • 2. Elimination of cytomegalovirus disease in liver transplant patients treated prophylactically with combination cytomegalovirus hyperimmune globulin and ganciclovir.
    Prian GW; Koep LJ
    Transplant Proc; 1994 Oct; 26(5 Suppl 1):54-5. PubMed ID: 7940977
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence and therapy of cytomegalovirus disease after liver transplantation.
    Wiens M; Lefèbre B; Blumhardt G; Schmidt CA; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1985-6. PubMed ID: 8385829
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.
    Slifkin M; Ruthazer R; Freeman R; Bloom J; Fitzmaurice S; Fairchild R; Angelis M; Cooper J; Barefoot L; Rohrer R; Snydman DR
    Liver Transpl; 2005 Dec; 11(12):1597-602. PubMed ID: 16315314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ganciclovir plus cytomegalovirus immune globulin to treat CMV pneumonia in orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG-Study Group.
    George MJ; Snydman DR; Werner BG; Dougherty NN; Griffith J; Rohrer RH; Freeman R; Jenkins R; Lewis WD
    Transplant Proc; 1993 Oct; 25(5 Suppl 4):22-4. PubMed ID: 8212303
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of cytomegalovirus infection in high-risk recipients after renal transplantation: prophylaxis by hyperimmunoglobulins or DHPG treatment?
    Tenschert W; Gonnermann D; Meyer-Moldenhauer WH; Cremaschi L; Huland H
    Transplant Proc; 1993 Dec; 25(6):3256-8. PubMed ID: 8266533
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute rejection, cytomegalovirus infection and endothelial dysfunction early after heart transplantation.
    Sabaté M; Manito N; Cequier A; Roca J; Mauri J; Jara F; Gomez-Hospital JA; Ruiz-Majoral A; Sala J; Alcaide P
    Transplant Proc; 1995 Aug; 27(4):2346-8. PubMed ID: 7652837
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy.
    Sanchez-Turrión V; Cuervas-Mons V; Portero F; Barrios C; Garrido A; Albillos A
    Transplant Proc; 1993 Apr; 25(2):1786. PubMed ID: 8385824
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytomegalovirus infection with perineal pain after living donor liver transplantation: report of four cases.
    Sakamoto S; Taira K; Egawa H; Takada Y
    Transpl Infect Dis; 2007 Mar; 9(1):37-41. PubMed ID: 17313470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir in the treatment of severe cytomegalovirus disease in liver transplant patients.
    Salmela K; Höckerstedt K; Lautenschlager I; Eklund B; Isoniemi H; Holmberg C; Ahonen J
    Transplant Proc; 1990 Feb; 22(1):238-40. PubMed ID: 2155492
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral prophylaxis in hepatic transplantation: preliminary report of a randomized trial of acyclovir and gancyclovir.
    Nakazato PZ; Burns W; Moore P; Garcia-Kennedy R; Cox K; Esquivel C
    Transplant Proc; 1993 Apr; 25(2):1935-7. PubMed ID: 7682357
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus infection and prophylaxis in heart transplantation.
    Laske A; Gallino A; Carrel T; Niederhäuser U; von Segesser LK; Turina MI
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1427-8. PubMed ID: 8382870
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of severe cytomegalovirus infections with ganciclovir and CMV hyperimmune globulin in liver transplant recipients.
    D'Alessandro AM; Pirsch JD; Stratta RJ; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1989 Jun; 21(3):3560-1. PubMed ID: 2545018
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
    J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of CMV in human lung transplants.
    Behrend M; Steinhoff G; Wagner TO; Haverich A
    Transplant Proc; 1990 Aug; 22(4):1822-3. PubMed ID: 2167541
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of transplant rejection in the presence of cytomegalovirus viremia.
    O'Hair DP; Johnson CP; Roza AM; Adams MB
    Transplant Proc; 1990 Aug; 22(4):1815-7. PubMed ID: 2167537
    [No Abstract]   [Full Text] [Related]  

  • 17. Critical evaluation of agents used in the treatment and prevention of cytomegalovirus infection in immunocompromised patients.
    Meyers JD
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):139-42, discussion 142-3. PubMed ID: 1648819
    [No Abstract]   [Full Text] [Related]  

  • 18. CMV infection after kidney transplantation in children.
    Lehnert A; Niaudet P; Broyer M
    Transplant Proc; 1996 Oct; 28(5):2805. PubMed ID: 8908068
    [No Abstract]   [Full Text] [Related]  

  • 19. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of ICAM-1 on hepatocytes precedes the lymphoid activation of acute liver allograft rejection and cytomegalovirus infection.
    Lautenschlager I; Höckerstedt K
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1429-30. PubMed ID: 8095108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.